title: De novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 clone.
authors.forename: Craig A
authors.initials: CA
authors.lastname: Portell
authors.forename: Mikkael A
authors.initials: MA
authors.lastname: Sekeres
authors.forename: Heesun J
authors.initials: HJ
authors.lastname: Rogers
authors.forename: Ramon V
authors.initials: RV
authors.lastname: Tiu
mesh_terms: D019943:Amino Acid Substitution; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D019008:Drug Resistance, Neoplasm / Q000187:drug effects / Q000235:genetics*; D005260:Female; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics*; D008875:Middle Aged; D020125:Mutation, Missense; D011087:Polycythemia Vera / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics*
chemical_list: D003561:Cytarabine; C507924:JAK2 protein, human; D053614:Janus Kinase 2